There are different approaches to cancer treatment and, for some types of cancer, the therapy may be individualized (precision medicine) based on information specific to the affected patient.
Treating cancer in dogs and cats hinges on the partnership between the primary care veterinarian and the veterinary oncologist. This collaborative team approach - with the pet patient and its owner at the core - is critical to the successful management of pets with cancer. This segment will delve into the wide array of treatment options that have emerged in the world of cancer care.
Dr. Chelsea Tripp kicks off this segment discussing some newer advancements in care that have fewer side effects than traditional IV chemotherapy. She introduces us to novel therapies in cancer care such as Gold Nanoparticles and Stelfonta® and explains their applications in treating pets with cancer.
Dr. Tim Fan expands on the discussion of how we can reduce the systemic toxicity associated with chemotherapy by directly and locally treating a tumor - highlighting malignant melanoma in dogs as an example. He describes a novel anchoring strategy for retaining potent anti-tumor cytokines to their location of injection, thereby exerting potent immune-activating properties locally. He then shares results of a trial utilizing this method for treating dogs with malignant melanoma.
We then turn our attention to learning about several other specific therapies and their indications for treating pets with cancer. Dr. Jeffrey Bryan begins by explaining the role of genetics and epigenetics as it relates to tumor cells and how these can be modified or targeted with specific drugs. He explains how the immune system interacts with tumors and their microenvironment and how that contributes to the destruction of cancer cells.
We also have another exciting addition to our armament for cancer care. Dr. Doug Thamm introduces us to immune checkpoint inhibitors and explains how these agents can be used alone and in combination with other forms of cancer treatment. He highlights which dogs stand most to benefit with this type of therapy.
Running time: 1 hr 49 mins (including 8 mins of Q and A)
Approved for 2 hrs of CE credit by AAVSB RACE and NY State
You might also like
Dispelling Cancer Treatment Myths And Addressing Quality Of Life Of Affected Dogs And Cats
12/11/2024
Cancer is a word that can evoke a lot of fear and uncertainty, especially when it affects our animal...
Read
More
Supporting The Cancer Patient: Managing Cancer Pain, Nutritional Needs Of Patients, And Supporting The Caregiver Through It All
12/04/2024
Aside from the plan prescribed to treat a pet’s cancer, we have to ensure that we are addressi...
Read
More
Cancer Diagnostics - What Is Helpful? What Is Hype Or Truly Offers Hope?
10/30/2024
The mention of 'cancer' can evoke a wide range of emotions ranging from fear to concern to confusion...
Read
More
The Current Thinking About What Cancer Is And Its Possible Causes
10/23/2024
Cancer is a term that is often shrouded in uncertainty and fear, but gaining a clear understanding o...
Read
More
Mastering IMHA In Dogs - Part I: Approaches To Diagnosis And Standard Management
07/23/2024
This is the first of a two part series on the topic of immune-mediated hemolytic anemia (IMHA) in do...
Read
More
Caring For Chronic Kidney Disease (CKD) In The Dog - Quality Of Life And End Of Life Considerations
07/09/2024
The focus of this session is on maximizing the quality of life of dogs with chronic kidney disease (...
Read
More
